MAYINGLONG PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.16 CNY | -0.95% |
|
-3.59% | +12.32% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Mayinglong Pharmaceutical Group Co., Ltd. is a China-based company, principally engaged in pharmaceutical production, retailing and wholesaling businesses. The Company's pharmaceutical products are classified as drugs for hemorrhoid, including diosmin tablets, suppositories, pastes and granules, among others; drugs for cough, including levodropropizine oral solution and compound glycyrrhiza oral solution, as well as drugs for skin injuries, including products such as erythromycin ointment. The Company also provides specialty drugs. The Company is also engaged in the production and distribution of eye cream products with the brand named Mayinglong BaBao, as well as the provision of hospital clinical service. The Company distributes its products mainly in domestic markets.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +12.32% | 1.62B | |
| +20.11% | 43.75B | |
| +27.47% | 22.06B | |
| +14.49% | 14.46B | |
| +13.37% | 13.62B | |
| +39.63% | 11.61B | |
| -9.54% | 6.9B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +9.64% | 5.32B |
- Stock Market
- Equities
- 600993 Stock
- News Mayinglong Pharmaceutical Group Co., LTD.
- Mayinglong Pharmaceutical Receives Registration Approval for New Colorectal Treatment
